Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Archives of Pathology & Laboratory Medicine|March 26, 2021
Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing SarcomaSteven G DuBois, Mark D Krailo, Allen Buxton, et al.Journal of Surgical Oncology|January 19, 2016
Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology GroupCarol D Morris, Lisa A Teot, Mark L Bernstein, et al.Pediatric Blood & Cancer|September 8, 2021
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology GroupAnderson B Collier, Mark D Krailo, Ha M Dang, et al.Pediatric Blood & Cancer|December 3, 2014
Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology GroupDaniel M Lerman, Michael J Monument, Elizabeth McIlvaine, et al.International Journal of Radiation Oncology, Biology, Physics|October 27, 2022
Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology GroupSafia K Ahmed, Brent G Witten, William S Harmsen, et al.International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology GroupSafia K Ahmed, R Lor Randall, Steven G DuBois, et al.European Journal of Cancer (Oxford, England : 1990)|July 9, 2022
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology GroupPooja Hingorani, Mark Krailo, Allen Buxton, et al.Pediatric Blood & Cancer|July 1, 2016
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcomaPeter M Anderson, Stefan S Bielack, Richard G Gorlick, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2024
Mapping the Single-Cell Differentiation Landscape of OsteosarcomaDanh D Truong, Corey Weistuch, Kevin A Murgas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosisP A Meyers, M D Krailo, M Ladanyi, et al.Pageof 3